Allspring Global Investments Holdings LLC Sells 1,495 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Allspring Global Investments Holdings LLC trimmed its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 31.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,308 shares of the real estate investment trust’s stock after selling 1,495 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Omega Healthcare Investors were worth $135,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the company. Friedenthal Financial bought a new position in Omega Healthcare Investors in the third quarter valued at approximately $761,000. Blue Trust Inc. boosted its position in Omega Healthcare Investors by 438.7% in the third quarter. Blue Trust Inc. now owns 1,433 shares of the real estate investment trust’s stock valued at $58,000 after buying an additional 1,167 shares in the last quarter. V Square Quantitative Management LLC boosted its position in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after buying an additional 323 shares in the last quarter. DiNuzzo Private Wealth Inc. acquired a new stake in Omega Healthcare Investors in the third quarter valued at approximately $33,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Omega Healthcare Investors by 5.9% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 48,043 shares of the real estate investment trust’s stock valued at $1,955,000 after buying an additional 2,688 shares in the last quarter. 65.25% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. BMO Capital Markets raised their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Scotiabank increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Berenberg Bank assumed coverage on Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price on the stock. Finally, Wells Fargo & Company restated an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and an average price target of $39.70.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $40.01 on Tuesday. The business has a 50 day moving average of $40.49 and a 200 day moving average of $36.12. The company has a market capitalization of $10.32 billion, a price-to-earnings ratio of 29.42, a PEG ratio of 1.37 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 5.79.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a $0.67 dividend. The ex-dividend date is Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.70%. Omega Healthcare Investors’s payout ratio is currently 197.06%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.